Volume Alert - VRX 136.16 Valeant Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 11:27 AM

Volume Alert - VRX 136.16 Valeant Pharmaceuticals International $VRX Hit a high today of 136.50 Closing the day 10:30 at 136.16 +1.95 +1.45% With a day low of 132.73 and a total volume of 3,820,934.

VRX Recent Posts: http://investorshangout.com/Valeant-Pharmaceu...VRX-53038/

VRX Valeant Pharmaceuticals International Recent Headline News

Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman
at The Street - 28 mins ago
Valeant says it can't justify $219 a share offer to shareholders.
ZTS: 43.91 (+0.77), AGN: 210.73 (+12.08), VRX: 135.65 (+1.44), ACT: 248.52 (+4.75)

Actavis to spend $66B on Allergan
By TOM MURPHY - AP - 40 mins ago
Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.
DRTX: 23.94 (+0.19), AGN: 210.73 (+12.08), ACT: 248.52 (+4.75), VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Actavis Nabs Allergan For $66 Billion; Valeant Folds
at Investor's Business Daily - 1 hr 10 mins ago
One of the most widely rumored deals in pharma came to fruition Monday, as Actavis (ACT) agreed to acquire Allergan (AGN) for $66 billion in cash and stock. Allergan stock was up more than 7%, near 213, and Actavis stock up nearly 4%, near 253, in...
AGN: 210.73 (+12.08), VRX: 135.65 (+1.44), ACT: 248.45 (+4.68)

Time to move on: Valeant chief says $219 too rich
Seeking Alpha - at Seeking Alpha - 1 hr 13 mins ago

ACT: 248.45 (+4.68), VRX: 135.65 (+1.44)

Valeant Comments On Allergan Announcement
PR Newswire - 1 hr 58 mins ago
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock.
AGN: 210.77 (+12.12), ACT: 248.58 (+4.81), VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge
at Investor's Business Daily - 2 hrs 15 mins ago
Stock futures pointed modestly lower ahead of Monday's open as merger news stirred some of the most notable premarket stock moves. Dow futures sifted 27.7 points below fair market value. Nasdaq 100 futures were 9.1 points lower, and S&P 500 futures...
AGN: 210.77 (+12.12), HAS: 56.31 (+2.29), VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), HAL: 50.68 (-4.40), DIS: 90.31 (-0.49), DWA: 22.28 (-3.74), BHI: 66.73 (+6.84)

Today's Market: Pharma And Tech Companies In Focus This Morning
Matthew Smith - at Seeking Alpha - 2 hrs 20 mins ago

AGN: 210.77 (+12.12), VRX: 135.65 (+1.44), ACT: 248.63 (+4.86), LNKD: 222.45 (-11.44), FB: 74.13 (-0.75), MSFT: 49.26 (-0.32), GOOG: 534.89 (-9.51)

Actavis Rumored to be Close to Acquiring Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 27 mins ago
As per market rumors, Actavis (ACT) is closing in on a deal to acquire Allergan (AGN) for over $65.5 billion.
DRTX: 23.94 (+0.19), ZTS: 43.91 (+0.77), AGN: 210.77 (+12.12), ACT: 248.58 (+4.81), VRX: 135.65 (+1.44)

Tracking Bill Ackman's Pershing Square Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 6:40AM CST

ZTS: 43.91 (+0.77), AGN: 210.77 (+12.12), HLF: 38.48 (-0.02), VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), HHC: 142.97 (-0.71), PAH: 25.70 (+0.20), CP: 204.86 (+0.30), APD: 134.99 (+0.28), BKW: 32.05 (-0.24)

Wall Street Breakfast: Nikkei Dives As Japan Slips Into Recession
Wall Street Breakfast - Seeking Alpha - Mon Nov 17, 5:30AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Top long idea...
VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), F: 15.35 (+0.21), FB: 74.13 (-0.75), PFE: 29.95 (-0.39), AGN: 210.79 (+12.14), YHOO: 51.35 (-0.40), PBR: 9.61 (-0.34), DFS: 64.86 (-0.12), DTSI: 32.78 (-0.25), SPY: 203.88 (-0.36), LNKD: 222.45 (-11.44), QQQ: 102.51 (-0.71), AME: 51.12 (-0.58), MRK: 59.71 (+0.64), AOL: 46.28 (+0.24), AZN: 72.14 (-0.71), GM: 32.16 (+0.37), CVEO: 10.53 (-0.11), DD: 70.50 (-0.30)

Actavis near deal to acquire Allergan for $210-220/share
Seeking Alpha - at Seeking Alpha - Sun Nov 16, 2:51PM CST

AGN: 210.79 (+12.14), ACT: 248.64 (+4.87), VRX: 135.65 (+1.44)

Tracking Lou Simpson's SQ Advisors Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Sun Nov 16, 10:03AM CST

BAM: 49.79 (+0.18), VRX: 135.65 (+1.44), LBTYK: 45.43 (-0.57), CCK: 48.22 (+0.68), WFC: 53.21 (-0.14), ORCL: 40.93 (+0.09), UPS: 106.40 (-0.43), MCO: 100.43 (-0.04), T: 35.84 (-0.06), USB: 43.75 (+0.02), TEL: 60.90 (-0.63), DTV: 87.22 (-0.33), BRK.B: 145.40 (-0.12), BRK.A: 218,035.00 (+12.00), SCHW: 28.57 (-0.30)

Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Sat Nov 15, 10:45AM CST

KMI: 39.78 (+0.41), VRX: 135.65 (+1.44), HAL: 50.69 (-4.39), KMP: 97.14 (+0.89), BAC: 17.11 (-0.03), TDW: 37.56 (-0.23), VPRT: 67.60 (+0.80), ORCL: 40.93 (+0.09), PRI: 51.71 (-0.34), EPB: 41.87 (+0.42), ESRX: 78.35 (+0.48), EQIX: 221.58 (-0.51), JPM: 60.28 (unch), KMR: 98.09 (+1.13), MSFT: 49.26 (-0.32), CMCSA: 54.12 (+0.02), SCHW: 28.57 (-0.30)

After Yesterday's Rally of 1.80% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Nov 14, 3:59PM CST
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $131.34 to a high of $134.64. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $133.84 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 135.65 (+1.44)

Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 1:20PM CST
Merck KGaA (MKGAF) reported third-quarter 2014 earnings of $1.53 per American Depositary Receipt (ADR), up 0.2% from the year-ago quarter.
LCI: 47.36 (+0.48), VRX: 135.65 (+1.44), ADHD: 3.45 (-0.21)

Valeant Should Drop Allergan Bid And Go For Zoetis
Kanak Kanti De - at Seeking Alpha - Fri Nov 14, 7:30AM CST

ZTS: 43.91 (+0.77), AGN: 210.85 (+12.20), VRX: 135.65 (+1.44), ACT: 248.67 (+4.90)

Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:28PM CST
A report from Bloomberg stated that Actavis is in discussions to Allergan for a deal worth at least $60 billion.
ZTS: 43.91 (+0.77), AGN: 210.85 (+12.20), ACT: 248.67 (+4.90), VRX: 135.65 (+1.44)

Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey
CNW Group - Thu Nov 13, 4:00PM CST
Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy
VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Bausch Health Companies Inc. (BHC) Stock Research Links

BHC Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

LifeSecure Expands with Starscape Agency Launch

LifeSecure's Strategic Move into the Insurance Space LifeSecure Holdings Corporation is planting new roots with its latest venture, Starscape Insurance Agency. This ain't just another splash in the kiddie pool, buddy. This is a big step in bolstering its standing in the insurance sector, focusing sharply on health insurance solutions for individuals, families, and even...

Roadrunner's Bold Move: New LTL Service and Rate Hike

When you shake up the status quo in logistics, you better be ready for the ride. Roadrunner Freight is doing just that with the launch of its first-ever outbound Canada-to-U.S. LTL service. They're shaking up a market that's been bogged down with inefficiencies for far too long. This isn't just another lane to add to a map; it's a new passage for Canadian goods, paving a...

WellBe Taps New Tech Chief to Elevate Home Care

In a move that's got the healthcare world buzzing, WellBe Senior Medical just brought in a heavyweight to steer its digital ship. They've appointed Jeffrey Brown as their new Chief Digital & Information Officer. What's shaking? Brown's stepping into the ring to tackle the age-old healthcare dilemma: making tech work smarter, not harder, especially at home. From High-Tech...

Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Effective Youth Hockey Skills: Mastering the Basics

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Galien Recognizes Kerry for Transformative Global Health Work

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...